These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 3133927

  • 1. Antitumor effect of combined intraperitoneal administration of human recombinant interferon-beta and interferon-gamma against intraabdominal carcinomatosis in nude mice.
    Kondo H, Tanaka N, Naomoto Y, Orita K.
    Acta Med Okayama; 1988 Apr; 42(2):69-75. PubMed ID: 3133927
    [Abstract] [Full Text] [Related]

  • 2. Antitumor effect of recombinant human interferon-beta and interferon-gamma in combination against human colon cancer cell line in vitro and in nude mice.
    Kondo H, Tanaka N, Naomoto Y, Orita K.
    Jpn J Cancer Res; 1987 Nov; 78(11):1258-65. PubMed ID: 3121561
    [Abstract] [Full Text] [Related]

  • 3. [Combined effect of human recombinant interferon-beta and interferon-gamma against an experimental model of peritonitis carcinomatosa in nude mice].
    Kondo H, Tanaka N, Naomoto Y, Orita K.
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1836-40. PubMed ID: 3109328
    [Abstract] [Full Text] [Related]

  • 4. Changes in lymphocyte subsets following multiple administration of recombinant interleukin-2 plus recombinant interferon-beta or -gamma in tumor-bearing mice.
    Iigo M, Nishikata K, Nakajima Y, Moriyama M.
    Jpn J Cancer Res; 1989 Jun; 80(6):554-61. PubMed ID: 2527216
    [Abstract] [Full Text] [Related]

  • 5. Antitumor effect of human recombinant interferon-gamma alone and in combination with adriamycin on a human colon cancer cell line (RPMI 4788) in vitro and in nude mice.
    Kondo H, Tanaka N, Orita K.
    Jpn J Cancer Res; 1987 Dec; 78(12):1400-8. PubMed ID: 3123441
    [Abstract] [Full Text] [Related]

  • 6. [Antitumor efficacy of recombinant interferon-beta on human glioma].
    Miyao Y, Shimizu K, Okamoto Y, Matsui Y, Tsuda N, Yamada M, Tamura K, Mogami H.
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):490-4. PubMed ID: 3813577
    [Abstract] [Full Text] [Related]

  • 7. Effects of interleukin-2 and interferon-beta treatment on lymphocytes in various tumor-bearing mice.
    Iigo M, Nishikata K, Nakajima Y, Moriyama M.
    J Biol Regul Homeost Agents; 1989 Feb; 3(3):108-11. PubMed ID: 2516403
    [Abstract] [Full Text] [Related]

  • 8. Antitumor effect of combination of murine recombinant interferon beta, murine recombinant interferon gamma and human recombinant interleukin-2 in MethA-bearing mice.
    Itoh T, Sakata Y, Yoshida Y, Tsushima K, Suzuki H, Saitoh S, Tamura Y, Ogasawara H, Sugimoto N, Takemori H.
    Cancer Immunol Immunother; 1990 Feb; 32(2):88-94. PubMed ID: 2126986
    [Abstract] [Full Text] [Related]

  • 9. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 10. In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors.
    Iigo M, Sakurai M, Tamura T, Saijo N, Hoshi A.
    Cancer Res; 1988 Jan 15; 48(2):260-4. PubMed ID: 2446744
    [Abstract] [Full Text] [Related]

  • 11. [Antitumor effects of recombinant human leukocyte interferon (rIFN-alpha A) on human malignomas transplanted into nude mice].
    Hashizume S.
    Gan To Kagaku Ryoho; 1985 Feb 15; 12(2):284-8. PubMed ID: 3970552
    [Abstract] [Full Text] [Related]

  • 12. Antitumor effect of human recombinant interferon-gamma and -beta against human osteosarcoma transplanted into nude mice.
    Gomi K, Oka T, Morimoto M.
    J Pharmacobiodyn; 1986 Nov 15; 9(11):879-88. PubMed ID: 3104572
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Normal mouse skin lymphocyte, Langerhans cell, and keratinocyte responses to intradermal injections of interferon-alpha and interferon-gamma.
    Tong Y, Tucker SB.
    J Interferon Cytokine Res; 1995 Mar 15; 15(3):235-41. PubMed ID: 7584669
    [Abstract] [Full Text] [Related]

  • 15. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma.
    Black CM, Catterall JR, Remington JS.
    J Immunol; 1987 Jan 15; 138(2):491-5. PubMed ID: 3098846
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recombinant interferon alpha and gamma in combination as treatment for metastatic renal cell carcinoma.
    Quesada JR, Evans L, Saks SR, Gutterman JU.
    J Biol Response Mod; 1988 Jun 15; 7(3):234-9. PubMed ID: 3134511
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.